China

8 Vaccines Approved for Use in China

Protein Subunit

Anhui Zhifei Longcom

Zifivax

Approved in 4 countries
21 trials in 5 countries
Approval Source: reuters.com
Non Replicating Viral Vector

CanSino

Convidecia

Approved in 10 countries
14 trials in 6 countries
Approval Source: reuters.com
Inactivated

Shenzhen Kangtai Biological Products Co

KCONVAC

Approved in 2 countries
7 trials in 1 country
Approval Source: reuters.com
Inactivated

Sinopharm (Beijing)

Covilo

Approved in 93 countries
39 trials in 18 countries
Approval Source: reuters.com
Inactivated

Sinopharm (Wuhan)

Inactivated (Vero Cells)

Approved in 2 countries
9 trials in 7 countries
Approval Source: reuters.com
Inactivated

Sinovac

CoronaVac

Approved in 56 countries
42 trials in 10 countries
Approval Source: reuters.com
Protein Subunit

Livzon Mabpharm Inc

V-01

Approved in 1 country
7 trials in 3 countries
Approval Source: reuters.com
Non Replicating Viral Vector

CanSino

Ad5-nCoV-IH

Approved in 1 country
5 trials in 4 countries
Approval Source: reuters.com

35 in Clinical Trials in China

Protein Subunit

Anhui Zhifei Longcom

Zifivax

Approved in 4 countries
21 trials in 5 countries
Protein Subunit

Livzon Pharmaceutical Group Inc

V-01

Protein Subunit

Sinocelltech

SCTV01C

12 trials in 2 countries
Protein Subunit

National Vaccine and Serum Institute

Recombinant SARS-CoV-2 Vaccine (CHO Cell)

Approved in 1 country
3 trials in 2 countries
Protein Subunit

West China Hospital

Recombinant (Sf9 cell)

9 trials in 5 countries
Protein Subunit

Clover

SCB-2019

15 trials in 13 countries
DNA

Inovio

INO-4800

10 trials in 9 countries
RNA

Pfizer/BioNTech

Comirnaty

Approved in 149 countries
100 trials in 31 countries
RNA

Walvax

mRNA

4 trials in 3 countries
RNA

Pfizer/BioNTech

BNT162b1

5 trials in 3 countries
Non Replicating Viral Vector

CanSino

Ad5-nCoV-IH

Approved in 1 country
5 trials in 4 countries
Non Replicating Viral Vector

CanSino

Convidecia

Approved in 10 countries
14 trials in 6 countries
Replicating Viral Vector

Wantai

DelNS1-2019-nCoV-RBD-OPT1

5 trials in 3 countries
Inactivated

Shenzhen Kangtai Biological Products Co

KCONVAC

Approved in 2 countries
7 trials in 1 country
Inactivated

Sinopharm (Wuhan)

Inactivated (Vero Cells)

Approved in 2 countries
9 trials in 7 countries
Inactivated

Sinopharm (Beijing)

Covilo

Approved in 93 countries
39 trials in 18 countries
Inactivated

Sinovac

CoronaVac

Approved in 56 countries
42 trials in 10 countries
Protein Subunit

Livzon Pharmaceutical Group Inc

V-01-351/V-01D

2 trials in 1 country
Protein Subunit

Shanghai Zerun Biotechnology, Walvax Biotechnology

202-CoV

6 trials in 2 countries
RNA

Stemirna Therapeutics Co Ltd

mRNACOVID-19 Vaccine

3 trials in 2 countries
Non Replicating Viral Vector

Shenzhen Geno-Immune Medical Institute

LV-SMENP

2 trials in 1 country
RNA

AIM Vaccine

LVRNA009

3 trials in 2 countries
Non Replicating Viral Vector

AMMS

Ad5-nCoV

Replicating Viral Vector

Shenzhen Geno-Immune Medical Institute

Covid-19/aAPC

RNA

CSPC ZhongQi Pharmaceutical Technology

SYS6006

3 trials in 1 country
Inactivated

China National Biotec Group Company Limited

Omicron COVID-19 Vaccine (Vero Cell)

3 trials in 1 country
Inactivated

Sinovac

COVID-19 Vaccine (Vero cell), Inactivated (CZ strain)

Inactivated

Sinovac

COVID-19 Vaccine (Vero cell), Inactivated (Omicron variant)

Protein Subunit

National Vaccine and Serum Institute

GEN2-Recombinant COVID-19 Vaccine (CHO Cells)

VLP

Yantai Patronus Biotech Co Ltd

LYB001

6 trials in 1 country
RNA

Walvax

AWcorna

Approved in 1 country
4 trials in 3 countries
RNA

CanSino Biologics Inc

COVID-19 mRNA Vaccine

3 trials in 1 country
RNA

Stemirna Therapeutics Co Ltd

SW-BIC-213

4 trials in 2 countries
Protein Subunit

Livzon Pharmaceutical Group Inc

V-01-351/V-01-B5

Protein Subunit

Livzon Pharmaceutical Group Inc

V-01/V-01-B5